Tell Your Value Story with Confidence

Clinical efficacy alone is not enough. Payers, clinicians, and patients demand compelling narratives that demonstrate differentiated value, real-world impact, and meaningful outcomes. Our Value Evidence and Medical Strategy services combine robust scientific evidence with strategic communication to build credibility, support reimbursement, and drive adoption from launch through lifecycle. 

Patient adherence programs to improve healthcare access

Evidence Platform Development

Global Value Dossier Development 

Create comprehensive evidence platforms that establish your value proposition across stakeholders and markets. Our global value dossiers integrate clinical, economic, and patient-reported outcomes into cohesive narratives that support consistent messaging while enabling country-specific adaptation. 

 

Medical and Scientific Communication Strategy 

Develop compelling narratives and communication materials that translate complex evidence into clear, persuasive messages for diverse audiences. From publication planning to medical affairs support, we ensure your value story reaches and resonates with key stakeholders. 

Consulting for pharmaceutical patient adherence programs​

Real-World and Patient Evidence

Real-World Evidence Generation 

Design and execute strategies to capture real-world data that demonstrates effectiveness, safety, and value in clinical practice. We leverage patient registries, observational studies, digital health tools, and real-world data platforms to generate evidence that addresses payer uncertainties and strengthens reimbursement cases throughout the product lifecycle. 

 

Patient-Centered Research 

Integrate patient perspectives and patient-reported outcomes into your evidence strategy. Our patient-centered research captures quality of life impacts, treatment burden, and patient preferences, providing the humanized evidence that resonates with decision-makers and differentiates your innovation. 

 

Value Differentiation Studies 

Generate targeted evidence that highlights your product’s unique benefits versus competitors. We design comparative effectiveness studies, real-world comparative analyses, and value demonstration projects that substantiate claims and defend market position. 

 

Real-World Evidence Strategy 

Design strategies to generate real-world data and evidence that address evidence gaps and support value claims throughout the product lifecycle. Our RWE approaches leverage digital tools, patient registries, and observational studies to strengthen reimbursement cases and defend value post-launch. 

Strategic Analysis and Program Development

Care and Treatment Pathway Analysis 

Map current treatment journeys and identify opportunities to optimize patient flow, improve outcomes, and position your therapy effectively. Our pathway analyses inform positioning strategy, stakeholder engagement, and evidence generation priorities while identifying barriers to adoption. 

 

Patient Support Program Strategy and Implementation 

Design programs that improve access, adherence, and outcomes while generating valuable real-world evidence. We develop patient support program strategies, assess implementation feasibility, and evaluate program effectiveness to optimize patient access and commercial success. 

 

Early Access Program Assessment and Strategy 

Evaluate opportunities for compassionate use, managed access programs, and pre-approval access schemes. Our assessments identify feasible pathways, regulatory requirements, and strategic implications to accelerate patient access while building evidence and stakeholder relationships. 

Why It Matters

Strong value evidence is the foundation of successful market access. 

 

Without Compelling Value Evidence: 

  • Differentiation is lost – Generic value claims fail to convince payers and clinicians 
  • Reimbursement is compromised – Weak evidence leads to restrictive coverage or unfavorable pricing 
  • Adoption is delayed – Clinicians and patients need compelling reasons to switch from established therapies 
  • Competitive advantage erodes – Competitors with superior evidence and narrative capture market share 

 

Compelling Value Evidence Delivers: 

  • Stronger reimbursement outcomes – Evidence that addresses payer concerns fosters favorable access decisions 
  • Faster adoption – Clear, credible value stories accelerate clinical and patient uptake 
  • Sustainable competitive positioning – Differentiated evidence protects market share against new entrants 
  • Lifecycle value optimization – Ongoing evidence generation supports indication expansions, label updates, and value optimization until the loss of exclusivity  

Our Approach 

We combine scientific rigor with strategic storytelling to create evidence that works.

Our teams bring: 

  • Deep therapeutic area expertise across oncology, rare diseases, immunology, cell and gene therapies, and beyond, with experience in a broad range of therapeutic areas 
  • Integration with health economics, market access strategy, and regulatory affairs to ensure evidence alignment 
  • Experience leveraging digital health tools, real-world data platforms, and innovative study designs to generate compelling evidence efficiently 
  • Understanding of stakeholder priorities—what payers, clinicians, patients, and regulators need to hear and how they need to hear it 
  • Proven track record supporting successful launches and lifecycle management across global markets, including over 150 global value dossiers developed in the past 5 years 

 

Whether building your initial value proposition or defending established therapies against new competition, our value evidence and medical strategy capabilities ensure your story stands out and your innovation achieves its full potential. 

 

Ready to strengthen your value evidence strategy?

Contact us to discuss your approach.

At the centre of every successful access program is an amazing patient program team, uniting skills, understanding, and innovation to empower patients and redefine their healthcare experiences.

Senior Product Director

We are very happy with the program, some feedback (from a KOL) commented “the best program” he has seen”.

Head of Marketing

Extensive insights into the patient journey and needs through partnering with advocacy organizations have provided a truly valuable service offering to our patients in a therapy area of high need. The team truly went to great lengths to understand how the condition impacts their lives and now offer a support program of great use and high value. By incorporating rigorous KPI and ROI measurements into regular reporting, the program offers a flexible solution for our patient support requirements, which can be scaled to ensure sustainability.

Country Medical Director